Roche (OTCMKTS:RHHBY) Stock Rating Lowered by Hsbc Global Res

Hsbc Global Res cut shares of Roche (OTCMKTS:RHHBY) from a strong-buy rating to a hold rating in a research report sent to investors on Monday morning,Zacks.com reports.

A number of other equities research analysts also recently issued reports on RHHBY. HSBC downgraded Roche from a “buy” rating to a “hold” rating in a research report on Monday. Morgan Stanley assumed coverage on Roche in a research note on Wednesday, February 12th. They issued an “equal weight” rating on the stock. UBS Group raised Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 13th. Finally, Sanford C. Bernstein raised Roche to a “strong-buy” rating in a research note on Thursday, January 30th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating, one has assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold”.

Roche Stock Performance

OTCMKTS:RHHBY opened at $40.77 on Monday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.26. Roche has a 1 year low of $29.20 and a 1 year high of $44.31. The stock’s fifty day moving average price is $40.73 and its two-hundred day moving average price is $38.62.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Moloney Securities Asset Management LLC grew its stake in shares of Roche by 53.8% during the first quarter. Moloney Securities Asset Management LLC now owns 40,732 shares of the company’s stock valued at $1,672,000 after buying an additional 14,245 shares during the last quarter. Altrius Capital Management Inc grew its stake in shares of Roche by 3.6% during the first quarter. Altrius Capital Management Inc now owns 189,993 shares of the company’s stock valued at $7,818,000 after buying an additional 6,545 shares during the last quarter. Riverbridge Partners LLC boosted its holdings in shares of Roche by 6.7% during the first quarter. Riverbridge Partners LLC now owns 37,826 shares of the company’s stock worth $1,557,000 after purchasing an additional 2,381 shares during the period. Bard Financial Services Inc. increased its holdings in Roche by 25.3% during the 1st quarter. Bard Financial Services Inc. now owns 138,900 shares of the company’s stock valued at $5,716,000 after purchasing an additional 28,050 shares during the period. Finally, GAMMA Investing LLC raised its position in Roche by 59.5% during the 1st quarter. GAMMA Investing LLC now owns 12,850 shares of the company’s stock valued at $529,000 after purchasing an additional 4,794 shares during the last quarter.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.